» Articles » PMID: 26366076

Pre- and Postmortem Imaging of Transplanted Cells

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2015 Sep 15
PMID 26366076
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Therapeutic interventions based on the transplantation of stem and progenitor cells have garnered increasing interest. This interest is fueled by successful preclinical studies for indications in many diseases, including the cardiovascular, central nervous, and musculoskeletal system. Further progress in this field is contingent upon access to techniques that facilitate an unambiguous identification and characterization of grafted cells. Such methods are invaluable for optimization of cell delivery, improvement of cell survival, and assessment of the functional integration of grafted cells. Following is a focused overview of the currently available cell detection and tracking methodologies that covers the entire spectrum from pre- to postmortem cell identification.

Citing Articles

Cadaveric Stem Cells: Their Research Potential and Limitations.

Ciesla J, Tomsia M Front Genet. 2022; 12:798161.

PMID: 35003228 PMC: 8727551. DOI: 10.3389/fgene.2021.798161.


Mesenchymal Stem Cells Do Not Lose Direct Labels Including Iron Oxide Nanoparticles and DFO-Zr Chelates through Secretion of Extracellular Vesicles.

Gao Y, Jablonska A, Chu C, Walczak P, Janowski M Membranes (Basel). 2021; 11(7).

PMID: 34209565 PMC: 8305565. DOI: 10.3390/membranes11070484.


Mesenchymal Stem Cells for Neurological Disorders.

Andrzejewska A, Dabrowska S, Lukomska B, Janowski M Adv Sci (Weinh). 2021; 8(7):2002944.

PMID: 33854883 PMC: 8024997. DOI: 10.1002/advs.202002944.


Comparative strategies for stem cell biodistribution in a preclinical study.

Wang F, Wang Z, Wang F, Dong K, Zhang J, Sun Y Acta Pharmacol Sin. 2019; 41(4):572-580.

PMID: 31705124 PMC: 7470780. DOI: 10.1038/s41401-019-0313-x.


Labeling of human mesenchymal stem cells with different classes of vital stains: robustness and toxicity.

Andrzejewska A, Jablonska A, Seta M, Dabrowska S, Walczak P, Janowski M Stem Cell Res Ther. 2019; 10(1):187.

PMID: 31238982 PMC: 6593614. DOI: 10.1186/s13287-019-1296-8.


References
1.
Trokowski R, Ren J, Kalman F, Sherry A . Selective sensing of zinc ions with a PARACEST contrast agent. Angew Chem Int Ed Engl. 2005; 44(42):6920-3. DOI: 10.1002/anie.200502173. View

2.
Schafer R, Kehlbach R, Muller M, Bantleon R, Kluba T, Ayturan M . Labeling of human mesenchymal stromal cells with superparamagnetic iron oxide leads to a decrease in migration capacity and colony formation ability. Cytotherapy. 2009; 11(1):68-78. DOI: 10.1080/14653240802666043. View

3.
Schormann W, Hammersen F, Brulport M, Hermes M, Bauer A, Rudolph C . Tracking of human cells in mice. Histochem Cell Biol. 2008; 130(2):329-38. DOI: 10.1007/s00418-008-0428-5. View

4.
Nejadnik H, Henning T, Do T, Sutton E, Baehner F, Horvai A . MR imaging features of gadofluorine-labeled matrix-associated stem cell implants in cartilage defects. PLoS One. 2012; 7(12):e49971. PMC: 3520977. DOI: 10.1371/journal.pone.0049971. View

5.
Amariglio N, Hirshberg A, Scheithauer B, Cohen Y, Loewenthal R, Trakhtenbrot L . Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009; 6(2):e1000029. PMC: 2642879. DOI: 10.1371/journal.pmed.1000029. View